±¹³»µµ¼
Àü°øµµ¼/´ëÇб³Àç
ÀÚ¿¬°úÇаè¿
±âŸ
2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.
Á¤°¡ |
6,000¿ø |
---|
6,000¿ø
180P (3%Àû¸³)
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà |
|
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
Ã¥¼Ò°³
ÀÌ Ã¥Àº ÇØ´ç ºÐ¾ß Àü°øÀÚµéÀ» À§ÇÑ ±³Àç °â Àü¹®¼ÀÌ´Ù.
¸ñÂ÷
º¸¼ö°úÁ¤ I
º¸¼ö°úÁ¤ I ÀÔ¹®(The CITI 101 Refresher Course)
Àӻ󿬱¸ ¿ª»ç¿Í À±¸®(History and Ethics)
±ÔÁ¤°ú ÀýÂ÷µé(Regulations and Process)
µ¿ÀǼ(Informed Consent, An Ongoing Process)
»çȸ°úÇÐ ¹× ÇൿÇÐ ¿¬±¸(Social & Behavioral Research (SBR))
µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ Àӻ󿬱¸(Records-based Research)
Ãë¾àÇÑ È¯°æÀÇ ¼ºÀÎ ÇÇÇèÀÚ ´ë»ó ¿¬±¸(Research Involving Vulnerable Adults)
½Ä¾àû Çã°¡´ë»ó ¿¬±¸¿Í ±¹Á¦Àӻ󿬱¸Áöħ(FDA Regulated Research and Conference on Harmonization)
ÀÓ»êºÎ ¹× ÅÂ¾Æ ´ë»ó ¿¬±¸(Studies with Pregnant Women and Fetuses)
¾î¸°ÀÌ ´ë»ó ¿¬±¸(Refresher Course 101-Research Involving Minors (45 CFR 46 Subpart D))
¼ö°¨ÀÚ ´ë»ó ¿¬±¸(Refresher Course 101-Research With Prisoners)
À¯ÀüÇÐ ¿¬±¸(Genetics Research)
CITI º¸¼ö°úÁ¤ I¸¦ ¸¶Ä¡¸ç(Completing the CITI Refresh Course)
º¸¼ö°úÁ¤ II
º¸¼ö°úÁ¤ II ÀÔ¹®(The CITI Biomedical 200 Level Refresh Course)
ÆÄÆ® I: Àӻ󿬱¸ À±¸®¿øÄ¢°ú ¿ª»ç-Áø·á¿Í ¿¬±¸(History and Ethics Refresher-Research vs. Practice)?59
Áø·á¿Í ¿¬±¸ÀÇ °æ°è
ÆÄÆ® I: º§¸óÆ® º¸°í¼-¼±Çà(Belmont Principles, Beneficence)
ÆÄÆ® I: º§¸óÆ® º¸°í¼-Á¤ÀÇ(Belmont Principles, Justice)
ÆÄÆ® I: º§¸óÆ® º¸°í¼-Àΰ£ Á¸Áß(Belmont Principles, Respect for Persons)
ÆÄÆ® II: IRB ±ÔÁ¤°ú ½É»çÀýÂ÷-Áö¼Ó½É»ç(Basic IRB Regulations and Review Process-Continuing Revies)
ÆÄÆ® II: IRB ±ÔÁ¤°ú ½É»ç ÀýÂ÷-IRB ±ÇÇÑ°ú ±¸¼º(Basic IRB Regulations and Review Process-The IRB)
ÆÄÆ® II: IRB ±ÔÁ¤°ú ÀýÂ÷-IRBÀÇ Ã¥¹«(Basic IRB Regulations and Process-IRB Responsibilities)
ÆÄÆ® II: IRB ±ÔÁ¤°ú ÀýÂ÷-IRB ½É»ç¸éÁ¦(Basic IRB Regulations and Process-Review for Exemption)
ÆÄÆ® III: ÇÇÇèÀÚ µ¿ÀǼ-À̵æ/À§Çè Æò°¡(Informed Consent-Benefits of Research)
ÆÄÆ® III: µ¿ÀǼ ±¸¼º¿ä¼Ò(The Elements of Informed Consent)
ÆÄÆ® III: µ¿ÀǼ-°ü·Ã ¹®¼(Informed Consent-The Informed Consent Document)
ÆÄÆ® III: µ¿ÀǼ-¸éÁ¦(Waiving the Requirement for Informed Consent)
ÆÄÆ® IV: »çȸ°úÇÐ ¹× ÇൿÇÐ ¿¬±¸-À§ÇèÀÇ ÃÖ¼ÒÈ(Social & Behavioral Research(SBR)-Minimizing Harms)
ÆÄÆ® IV: »çȸ°úÇÐ ¹× ÇൿÇÐ ¿¬±¸-À§Çè¿ä¼ÒÀÇ ÆľÇ(Social & Behavioral Research(SBR)-Identifying Risk)
ÆÄÆ® V: Ãë¾àÇÑ ÇÇÇèÀÚ±º-Á¤ÀÇ(Research with Protected Populations-Vulnerable Subjects: A Definition)
ÆÄÆ® V: Ãë¾àÇÑ ÇÇÇèÀÚ±º-ÀÓ»êºÎ ¹× ÅÂ¾Æ ´ë»ó ¿¬±¸(Pregnant Women and Fetuses)
ÆÄÆ® V: Ãë¾àÇÑ ÇÇÇèÀÚ±º-¾î¸°À̸¦ Æ÷ÇÔÇÏ´Â ¿¬±¸(Conducting Biomedical Research With Minors)
ÆÄÆ® V: Ãë¾àÇÑ ÇÇÇèÀÚ±º-¼ö°¨ÀÚ ´ë»ó ¿¬±¸(Vulnerable Subjects-Prisoners)
À¯ÀüÇÐ ¿¬±¸(Genetics Research)
ÀúÀÚ¼Ò°³
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
Àü°øµµ¼/´ëÇб³Àç ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.